This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
The planned newborn hepatitis B vaccine study in Guinea-Bissau will not proceed after the government refused to authorize it, the lead researcher said. The announcement follows a police search of the research project’s offices and seizure of vaccine doses.
HOW THIS BRIEF WAS MADE 5 outlets: 1 national · 1 international · 2 specialist · 1 trade press. Automated sourcing and summaries by the BLUF engine. Corrections
The study was to receive funding from the U.S. Centers for Disease Control and Prevention, according to The Guardian. The reported cancellation means the planned research will not take place in Guinea-Bissau; no further U.S. consequences are described in the articles.